What are the Historical Developments and Current Growth Metrics of the Metabolomics Services Market?
The metabolomics services market has seen considerable growth due to a variety of factors.
• The size of the metabolomics services market has expanded significantly in the recent past. It is projected to augment from $2.65 billion in 2024 to $3.04 billion in 2025, with a compound annual growth rate (CAGR) of 14.7%.
The historical period growth is largely due to a growing interest in biomarker discovery, an escalating demand for cutting-edge diagnostic tools, increased use in agricultural research, a growing number of clinical trials, and heightened awareness of metabolomics applications.
What is the Forecasted Market Size and CAGR for the Metabolomics Services Market?
The metabolomics services market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are that the metabolomics services market will experience swift expansion in the approaching years. The market is projected to attain a worth of $5.23 billion by 2029, with a compound annual growth rate (CAGR) of 14.5%.
The anticipated upsurge during the forecast period can be linked to the escalating incidence of cancer, growing demand for individualized medical treatments, broadening use in life sciences and biotechnology, an increased disease burden and ongoing improvements in healthcare facilities. Key emerging trends over the forecast span involve advancements in technology, machine learning, bioinformatics tools, the inclusion of artificial intelligence and the introduction of novel diagnostic instruments.
What Key Factors and Trends Are Driving The Growth Metabolomics Services Market?
The metabolomics services market is projected to expand due to the surging need for personalized medicine. Personalized medicine is a medical model that individualizes healthcare decisions and treatment plans for patients based on their genetic profile, environmental variables, and lifestyle. The elevated demand for this type of medicine is fueled by progress in genomic technologies. These advances allow for more accurate, custom treatments and a growing focus on patient-specific care for improved results. Metabolomics services improve personalized medicine by offering comprehensive metabolic profiles that enable treatments to be fine-tuned to each patient's distinctive biochemical conditions, resulting in more effective, specialized therapies. The Personalized Medicine Coalition, a professional association based in the United States, stated in 2022 that 12 new tailored medications were approved. This constitutes about 34% of all treatments approved in 2022, a notable rise from previous years. Consequently, the escalating need for personalized medicine is stimulating the growth of metabolomics services.
What Are The Market Segments In The Metabolomics Services Market?
The metabolomics servicesmarket covered in this report is segmented –
1) By Type: Untargeted Metabolomics Services, Targeted Metabolomics Services
2) By Product And Service: Metabolomics Bioinformatics Services, Chromatography, Mass Spectrometry, Other Product And Services
3) By End-User: Agriculture And Food, Biomedical And Pharmaceutical, Academic And Research Labs, Diagnostic Laboratories, Other End-users
Subsegments:
1) By Untargeted Metabolomics Services: Metabolite Profiling, Comprehensive Metabolomic Analysis, High-Throughput Metabolomics, Non-Targeted Mass Spectrometry Analysis, Data Mining and Interpretation Services
2) By Targeted Metabolomics Services: Quantitative Metabolite Analysis, Biomarker Discovery and Validation, Pathway Analysis, Specific Metabolite Measurement, Targeted Mass Spectrometry Services
Pre-Book The Metabolomics Services Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Metabolomics Services Market?
Leading corporations in the metabolomics services market are fostering innovation in diagnostic tools, aiming to improve the detection of diseases and individualized medicine. These tools encompass instruments and techniques utilized to determine and evaluate medical conditions, illnesses, or health issues, thereby supporting healthcare experts in precise diagnosis and therapeutic decision-making. To illustrate, Sapient Bioanalytics LLC, a biotech entity from the US, introduced targeted metabolite and lipid panels for biomarker discovery and swift insight generation in October 2023. These panels facilitate a concentrated effort in detecting and quantifying specific metabolites and lipids, thereby sharpening the accuracy of biomarker identification. They are specifically created for fast insight generation, ensuring prompt delivery of results, a crucial factor in research and clinical environments' decision-making process. The panels incorporate sophisticated data analysis tools to decode intricate metabolic profiles and offer implementable insights.
Who Are the Key Players In The Metabolomics Services Market?
Major companies operating in the metabolomics services market are:
• BASF SE
• Waters Corporation
• Bruker Corporation
• RTI International
• SCIEX
• BGI Group
• Fred Hutchinson Cancer Research Center
• OWL Inc.
• LECO Corporation
• Metabolon Inc.
• MetaSysX Inc.
• Nightingale Health
• Biocrates Life Sciences AG
• Human Metabolome Technologies America Inc.
• CosmosID
• Centre for Cellular and Molecular Platforms
• Creative Proteomics
• Cogentech
• Stemina Biomarker Discovery Inc.
• Thermal Management Innovations Corporation
• Afekta Technologies Ltd.
• MS-Omics
• Clinical Microbiomics
• DNA Xperts Private Limited
• Metware Biotechnology Co. Ltd
What Are The Regional Insights Into The Metabolomics Services Market?
North America was the largest region in the metabolomics services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metabolomics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
